Addressing Workforce Needs for Medication Treatment of Opioid Use Disorder

被引:6
|
作者
Thomas, Cindy Parks [1 ]
机构
[1] Brandeis Univ, Heller Grad Sch Social Policy & Management, 415 South St MS 035, Waltham, MA 02454 USA
关键词
medication assisted treatment; medication treatment; opioid use disorder; pharmacotherapy; BUPRENORPHINE; BARRIERS; CARE;
D O I
10.1097/ADM.0000000000000442
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Medication treatment of opioid use disorder (OUD) is recognized as an effective evidence-based treatment. It has been underused, in part due to challenges in recruiting and retaining a provider workforce that is able to prescribe and manage patients treated with OUD medications. A national goal should be: anyone with an OUD must have adequate access to a range of medications for treatment and support, provided in high-quality settings, and all programs receiving public or private funding should be so equipped. To accomplish this, it is important to understand what recruitment efforts are most successful, and what implementation strategies and service models are most effective. Building an adequate OUD treatment workforce, however, will require a system with adequate program resources and incentives, clinician and patient education to reduce stigma, limited regulatory burden, and adequate reimbursement and support high-quality services.
引用
收藏
页码:1 / 2
页数:2
相关论文
共 50 条
  • [1] Expanding the opioid use disorder medication treatment workforce in rural communities through the RCORP initiative
    Andrilla, C. Holly A.
    Woolcock, Sara C.
    Meyers, Kathleen
    Patterson, Davis G.
    JOURNAL OF RURAL HEALTH, 2025, 41 (01)
  • [2] Addressing Stigma in Medication Treatment of Adolescents With Opioid Use Disorder
    Bagley, Sarah M.
    Hadland, Scott E.
    Carney, Brittany L.
    Saitz, Richard
    JOURNAL OF ADDICTION MEDICINE, 2017, 11 (06) : 415 - 416
  • [3] Review of medication-assisted treatment for opioid use disorder
    Ghanem, Nessreen
    Dromgoole, Devin
    Hussein, Ahmad
    Jermyn, Richard T.
    JOURNAL OF OSTEOPATHIC MEDICINE, 2022, 122 (07): : 367 - 374
  • [4] Medication Treatment of Opioid Use Disorder
    Bell, James
    Strang, John
    BIOLOGICAL PSYCHIATRY, 2020, 87 (01) : 82 - 88
  • [5] Impact of intensity of behavioral treatment, with or without medication treatment, for opioid use disorder on HIV outcomes in persons with HIV
    Kennedy, Amy J.
    McGinnis, Kathleen A.
    Merlin, Jessica S.
    Edelman, E. Jennifer
    Gordon, Adam J.
    Korthuis, P. Todd
    Skanderson, Melissa
    Williams, Emily C.
    Wyse, Jessica
    Oldfield, Benjamin
    Bryant, Kendall
    Justice, Amy
    Fiellin, David A.
    Kraemer, Kevin L.
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2022, 132
  • [6] Understanding and co-managing medication treatment options for opioid use disorder
    Kay, Abigail
    Shmuts, Rachel
    Beck, Melanie
    INTERNAL AND EMERGENCY MEDICINE, 2022, 17 (07) : 2159 - 2165
  • [7] Medication assisted treatment discontinuation in pregnant and postpartum women with opioid use disorder
    Wilder, Christine
    Lewis, Daniel
    Winhusen, Theresa
    DRUG AND ALCOHOL DEPENDENCE, 2015, 149 : 225 - 231
  • [8] Understanding and co-managing medication treatment options for opioid use disorder
    Abigail Kay
    Rachel Shmuts
    Melanie Beck
    Internal and Emergency Medicine, 2022, 17 : 2159 - 2165
  • [9] The case for a medication first approach to the treatment of opioid use disorder
    Winograd, Rachel P.
    Presnall, Ned
    Stringfellow, Erin
    Wood, Claire
    Horn, Phil
    Duello, Alex
    Green, Lauren
    Rudder, Tim
    AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE, 2019, 45 (04) : 333 - 340
  • [10] A systematic review of rural-specific barriers to medication treatment for opioid use disorder in the United States
    Lister, Jamey J.
    Weaver, Addie
    Ellis, Jennifer D.
    Himle, Joseph A.
    Ledgerwood, David M.
    AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE, 2020, 46 (03) : 273 - 288